Can Philip Morris Rely on Pricing to Drive 2025 EPS Growth?

Philip Morris International reported strong Q1 2025 results, with adjusted EPS up 12.7% year-over-year to $1.69, driven by pricing, which contributed 6 percentage points to organic revenue growth of 10.2%; the company raised its full-year EPS forecast to $7.36-$7.49. While PM anticipates moderation in pricing gains later in the year, the company is investing in smoke-free products like ZYN, which saw shipment volumes rise 63%, and is outperforming competitors like Altria and Turning Point Brands, which are facing pricing pressures and margin challenges. PM's stock trades at a forward P/E of 23.19x, above the industry average, reflecting expectations of continued earnings growth of 13.7% in 2025 and 11.7% in 2026.

Analysis

Philip Morris International (PM) demonstrated robust financial health in Q1 2025, reporting a 12.7% year-over-year increase in adjusted earnings per share to $1.69, propelled by a 10.2% organic revenue growth. A significant contributor to this expansion was strategic pricing, which accounted for 6 percentage points of the revenue uplift, evidenced by an 8.3% increase in combustible pricing and approximately 3% in smoke-free products, excluding devices. This strong performance prompted PM to revise its full-year EPS forecast upwards to $7.36-$7.49. While management anticipates a moderation in gross pricing gains and potential negative geographic mix impacts through the remainder of the year, the smoke-free segment exhibits substantial momentum; ZYN shipment volumes surged 63% in the quarter, and the segment's gross margins expanded by an impressive 670 basis points to surpass 70%, now standing more than five percentage points above combustibles. This performance, further highlighted by a 180-basis-point overall gross margin enhancement from pricing alone, positions PM favorably against competitors such as Altria Group (MO) and Turning Point Brands (TPB). Altria, despite a 10.8% rise in net price realization for combustibles which supported operating income, is grappling with consumer downtrading to discount brands, thereby limiting its pricing flexibility, and its oral nicotine brand on! faces competitive pressures despite an 18% shipment growth. Turning Point Brands reported nearly tenfold year-over-year growth in modern oral pouch sales but experienced a 220-basis-point decline in gross margin due to mix effects and acknowledged the necessity for further investment to scale brands and improve profitability amidst rising costs and constrained pricing power. Philip Morris shares currently trade at a forward price-to-earnings ratio of 23.19X, notably above the industry average of 15.64X, reflecting market confidence supported by consensus estimates forecasting 13.7% earnings growth in 2025 and 11.7% in 2026.

Key Decisions for Investors

• Investors should recognize Philip Morris International's demonstrated pricing power and the rapid growth of its smoke-free segment, particularly ZYN, as key drivers justifying its premium valuation and positive earnings trajectory.
• It is advisable to monitor the sustainability of pricing contributions throughout the latter half of the year and the continued performance of smoke-free products, as these are crucial for sustaining the company's growth momentum and offsetting any moderation in combustible pricing.
• Consider PM's relatively stronger competitive positioning against peers like Altria and Turning Point Brands, which are facing more significant margin pressures and difficulties in fully leveraging pricing strategies amidst challenging consumer environments.